|Petition Title||Replace naloxone co-prescription requirement with FDA-approved opioid-reversal agents|
|Date Filed||7/27/2022 [Transmittal Sheet]|
The petitioner requests that the Board amend 18VAC85-21-40 to replace the requirement to co-prescribe naloxone with certain medications or conditions with a requirement to co-prescribe an FDA-approved opioid-reversal agent.
The petition for rulemaking will be published in the Virginia Register of Regulations on August 29, 2022. The petition will also be published on the Virginia Regulatory Town Hall at www.townhall.virginia.gov to receive public comment, which will open on August 29, 2022 and will close on September 19, 2022. The Board will consider the petition and all comments in support or opposition at the next meeting after the close of public comment, currently scheduled for October 6, 2022.
|Comment Period||Will begin 8/29/2022 and end on 9/19/2022|
|Name / Title:||William L. Harp, M.D. / Executive Director|
9960 Mayland Drive
|Telephone:||(804)367-4558 FAX: (804)527-4429 TDD: ()-|